| Literature DB >> 27659729 |
Qiu-Yue Yi1, Hong-Bao Li2, Jie Qi2, Xiao-Jing Yu2, Chan-Juan Huo2, Xiang Li2, Juan Bai2, Hong-Li Gao2, Bo Kou3, Kai-Li Liu2, Dong-Dong Zhang2, Wen-Sheng Chen4, Wei Cui5, Guo-Qing Zhu6, Xiao-Lian Shi2, Yu-Ming Kang7.
Abstract
Reactive oxygen species (ROS) in the brain are involved in the pathogenesis of hypertension. Epigallocatechin-3-O-gallate (EGCG), one of the active compounds in green tea, has anti-oxidant, anti-inflammatory and vascular protective properties. This study was designed to determine whether chronic infusion of EGCG into the hypothalamic paraventricular nucleus (PVN) attenuates ROS and sympathetic activity and delays the progression of hypertension by up-regulating anti-inflammatory cytokines, reducing pro-inflammatory cytokines (PICs) and decreasing nuclear factor-kappa B (NF-κB) activity, as well as restoring the neurotransmitters balance in the PVN of spontaneously hypertensive rats (SHR). Adult normotensive Wistar-Kyoto (WKY) rats and SHR received bilateral PVN infusion of EGCG (20μg/h) or vehicle via osmotic minipumps for 4 weeks. SHR showed higher mean arterial pressure, plasma proinflammatory cytokines and circulating norepinephrine (NE) levels compared with WKY rats. SHR also had higher PVN levels of the subunit of NAD(P)H oxidase (gp91phox), ROS, tyrosine hydroxylase, and PICs; increased NF-κB activity; and lower PVN levels of interleukin-10 (IL-10) and 67kDa isoform of glutamate decarboxylase (GAD67) than WKY rats. PVN infusion of EGCG attenuated all these changes in SHR. These findings suggest that SHR have an imbalance between excitatory and inhibitory neurotransmitters, as well as an imbalance between pro- and anti-inflammatory cytokines in the PVN. Chronic inhibition of ROS in the PVN restores the balance of neurotransmitters and cytokines in the PVN, thereby attenuating hypertensive response and sympathetic activity.Entities:
Keywords: Cytokines; Epigallocatechin-3-O-gallate; Hypertension; Neurotransmitters; Oxidative stress; Paraventricular nucleus
Mesh:
Substances:
Year: 2016 PMID: 27659729 DOI: 10.1016/j.toxlet.2016.09.010
Source DB: PubMed Journal: Toxicol Lett ISSN: 0378-4274 Impact factor: 4.372